Serum YKL-40 as a marker of liver fibrosis in patients with non-alcoholic fatty liver disease.

MLA

Kumagai, Erina, et al. “Serum YKL-40 as a Marker of Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease.” Scientific Reports, Oct. 2016, p. 35282. EBSCOhost, https://doi.org/10.1038/srep35282.

APA

Kumagai, E., Mano, Y., Yoshio, S., Shoji, H., Sugiyama, M., Korenaga, M., Ishida, T., Arai, T., Itokawa, N., Atsukawa, M., Hyogo, H., Chayama, K., Ohashi, T., Ito, K., Yoneda, M., Kawaguchi, T., Torimura, T., Nozaki, Y., Watanabe, S., & Mizokami, M. (2016). Serum YKL-40 as a marker of liver fibrosis in patients with non-alcoholic fatty liver disease. Scientific Reports, 35282. https://doi.org/10.1038/srep35282

Chicago

Kumagai, Erina, Yohei Mano, Sachiyo Yoshio, Hirotaka Shoji, Masaya Sugiyama, Masaaki Korenaga, Tsuyoshi Ishida, et al. 2016. “Serum YKL-40 as a Marker of Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease.” Scientific Reports, October, 35282. doi:10.1038/srep35282.